Treatment of Uterine Cancer In Israel

Cancer of the uterus is considered to be a malignant disease of organs responsible for the reproductive functions of the female body. In general, the cancer of the inner shell of the uterus (endometrioid), affecting the uterine neck and vagina, as well as penetrating into the wall of the uterus and into the lymph nodes. Unresolved type of cancer of the uterus is a sarcoma - malignant formation in the fibrous part of the organ. Usually, the tumor develops in women in the post-menstrual period.

Factors that affect the development of uterine cancer in girls include: early onset of sexual activity, menstrual cycle delay, repeated abortions, inability to give birth or absence of labor, inflammatory and venereal diseases, late menopause, hormonal imbalance, genetic predisposition, overweight , Diabetes mellitus, high blood pressure, medication.

The development of uterine cancer is characterized by pronounced symptomatology already at the initial stages of the disease. The main symptom of the disease is vaginal bleeding after menopause, sometimes quite large, large in terms of menstruation or menstrual irregularity in girls of childbearing age. The following signs may include pain in the lower abdomen and pelvis, symptoms of general cancer poisoning - blanching, total weakness, weight loss, the appearance of enlarged lymph nodes in the groin area.

Confirmation of the diagnosis and determination of the type and malignancy of uterine cancer in Israel is realized by ultramodern methods, of which:

* Transvaginal ultrasound, which makes the organs of the abdominal cavity and small pelvis visible in women;

* Biopsy - endometrium for a histological examination of a specimen of a part of the organ;

* Research curettage (curettage), is performed if the results of the biopsy have been questionable or little diagnostic material;

* Hysteroscopy - examination of the inside of the uterus and, if necessary, taking a specimen of tissue with a telescopic device inserted into the uterus through the vagina;

* An expanded blood test to prevent inflammatory foci in the body and anemia, and a blood test for the presence of certain anti-cancer antibodies (oncomarkers);

* PET-CT and MRI, which visualize the extent of tumor development in the uterus, the area of cancer in the lymph nodes, tumor metastasis to the lungs, liver and other parts of the body.

The choice of a method of treatment of a cancer of a uterus in Israel is defined by the sizes of malignant process, an attitude to keep reproductive function and a visual condition of the patient.

Surgical intervention is the most progressive treatment for uterine cancer in Israel. The degree of surgical intervention may remain at the level of removal of the uterus, but often requires the extraction of fallopian tubes, ovaries, pelvic lymph nodes. Israeli surgery is trying to perform operations with low-invasive laparoscopic methods.

In the later stages of oncology of the uterus and in the presence of metastatic images, a combination treatment of uterine cancer in Israel, including operations with radiation and chemotherapy, is selected.

Radiation therapy is carried out:

- radiation at a distance;

- brachytherapy - implantation of radioactive grains into the body of the tumor;

- 3D-conformal radiation therapy - irradiation with radiation packets that exactly correspond to the tumor form;

- IMRT - intensively modulated therapy with radio waves.

Chemotherapy protocols use the most effective methods for destroying circulating cancer antibodies, reducing the volume of the initial focus of uterine cancer and removing metastases.

Sometimes hormonal treatment of uterine cancer in Israel is used, which contributes to the destruction of the tumor.